Buys | $30,595 | 3 | 100 |
Sells | $0 | 0 | 0 |
Schmid John P. | director | 3 | $30,595 | 0 | $0 | $30,595 |
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's …
Over the last 12 months, insiders at Xeris Biopharma Holdings, Inc. have bought $30,595 and sold $0 worth of Xeris Biopharma Holdings, Inc. stock.
On average, over the past 5 years, insiders at Xeris Biopharma Holdings, Inc. have bought $316,957 and sold $151,244 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Schmid John P. (director) — $30,595.
The last purchase of 4,515 shares for transaction amount of $10,147 was made by Schmid John P. (director) on 2024‑08‑12.
2024-08-12 | Schmid John P. | director | 4,515 0.003% | $2.25 | $10,147 | +44.22% | ||
2024-08-09 | Schmid John P. | director | 4,285 0.0029% | $2.37 | $10,134 | +39.66% | ||
2024-05-10 | Schmid John P. | director | 5,400 0.004% | $1.91 | $10,314 | +68.18% | ||
2024-03-14 | Schmid John P. | director | 4,500 0.0032% | $2.16 | $9,720 | +32.63% | ||
2023-11-27 | SHERMAN JEFFREY W | director | 5,400 0.004% | $1.87 | $10,098 | +32.07% | ||
2023-11-20 | Pieper Steven | See Remarks | 28,000 0.0218% | $1.95 | $54,600 | +32.42% | ||
2023-11-20 | HALKUFF DAWN | director | 5,410 0.004% | $1.84 | $9,954 | +32.42% | ||
2023-11-17 | Shannon John Patrick Jr | See Remarks | 30,769 0.0206% | $1.64 | $50,400 | +34.46% | ||
2023-11-16 | Schmid John P. | director | 6,500 0.0045% | $1.51 | $9,815 | +51.59% | ||
2023-11-14 | PERSKY MARLA | director | 6,370 0.0047% | $1.58 | $10,058 | +52.24% | ||
2023-08-09 | Edick Paul R | See Remarks | 10,000 0.0073% | $2.38 | $23,794 | -9.79% | ||
2022-12-13 | Edick Paul R | See Remarks | 20,000 0.0152% | $1.45 | $29,000 | +34.75% | ||
2022-05-12 | Edick Paul R | See Remarks | 100,000 0.0681% | $1.40 | $140,380 | +0.66% | ||
2022-02-22 | Sale | PRESTRELSKI STEVEN | Chief Scientific Officer | 11,228 0.0085% | $2.42 | $27,158 | -32.35% | |
2021-11-15 | Edick Paul R | See Remarks | 20,000 0.0151% | $2.28 | $45,664 | -17.14% | ||
2021-11-12 | Shannon John Patrick Jr | See Remarks | 60,000 0.0484% | $2.10 | $126,000 | -2.80% | ||
2021-11-11 | Edick Paul R | See Remarks | 200,000 0.1644% | $2.08 | $415,760 | 0.00% | ||
2021-11-11 | Shannon John Patrick Jr | See Remarks | 40,000 0.033% | $2.09 | $83,500 | 0.00% | ||
2021-11-10 | Pieper Steven | See Remarks | 25,000 0.0216% | $2.00 | $49,918 | +9.47% | ||
2021-04-12 | Sale | PRESTRELSKI STEVEN | Chief Scientific Officer | 10,000 0.0156% | $4.07 | $40,725 | -34.99% |
Schmid John P. | director | 25200 0.0169% | $126,756.00 | 5 | 0 | +42.11% |
Redmile Group, LLC | 10 percent owner | 3000642 2.0128% | $15.09M | 2 | 0 | <0.0001% |
Edick Paul R | See Remarks | 2288064 1.5348% | $11.51M | 10 | 0 | +1.38% |
Palmetto Partners, Ltd. | 10 percent owner | 2110061 1.4154% | $10.61M | 1 | 0 | <0.0001% |
Shannon John Patrick Jr | See Remarks | 1408575 0.9448% | $7.09M | 6 | 0 | +19.99% |
$3,596,906 | 112 | 13.42% | $635.29M | |
$36,510,315 | 95 | 8.95% | $617.34M | |
$7,929,017 | 58 | 21.56% | $788.11M | |
$97,176 | 41 | 42.84% | $782.59M | |
$94,912,877 | 34 | -7.15% | $620.95M |
Increased Positions | 90 | +68.7% | 10M | +16.26% |
Decreased Positions | 45 | -34.35% | 9M | -13.7% |
New Positions | 32 | New | 3M | New |
Sold Out Positions | 14 | Sold Out | 1M | Sold Out |
Total Postitions | 176 | +34.35% | 65M | +2.57% |
Blackrock, Inc. | $52,158.00 | 7.03% | 10.82M | +87,097 | +0.81% | 2024-12-31 |
Vanguard Group Inc | $38,073.00 | 5.13% | 7.9M | +133,738 | +1.72% | 2024-12-31 |
Geode Capital Management, Llc | $16,154.00 | 2.18% | 3.35M | +17,956 | +0.54% | 2024-12-31 |
State Street Corp | $16,108.00 | 2.17% | 3.34M | +137,156 | +4.28% | 2024-12-31 |
Rosalind Advisors, Inc. | $14,966.00 | 2.02% | 3.1M | 0 | 0% | 2024-12-31 |
Morgan Stanley | $13,870.00 | 1.87% | 2.88M | +523,208 | +22.22% | 2024-12-31 |
Aigh Capital Management Llc | $12,411.00 | 1.67% | 2.57M | +389,192 | +17.81% | 2024-12-31 |
Renaissance Technologies Llc | $10,116.00 | 1.36% | 2.1M | +500,120 | +31.28% | 2024-12-31 |
Caxton Corp | $9,713.00 | 1.31% | 2.02M | -3M | -60.59% | 2024-12-31 |
Millennium Management Llc | $9,392.00 | 1.27% | 1.95M | +502,853 | +34.78% | 2024-12-31 |